Bharat Biotech said today it has resumed export of Covaxin, and has executed long-pending orders in November.
The company also said exports to additional countries will commence from December, according to a statement it shared on Twitter.
It was not immediately clear whether or not these exports were made under the global vaccine-sharing facility COVAX.
Covaxin, which is 78 per cent effective against severe cases of COVID-19, was approved for emergency use listing by the World Health Organization (WHO) earlier this month.
It is the only home-grown vaccine being used in India’s vaccination programme, although it accounts for only about 11 per cent of the nearly 1.23 billion doses administered so far.
Edits by EP News Bureau